Featured Post

Community-Acquired Pneumonia (CAP)

Image
pulmonary venous hypertension :: Article Creator Insmed Stock Soars On Pulmonary Arterial Hypertension Drug Trial Results Shares of Insmed (INSM) jumped nearly 30% Tuesday after the biopharmaceutical company reported positive results from a Phase 2 trial for its treatment of pulmonary arterial hypertension. The Bridgewater, N.J.-based company said the study was "evaluating the efficacy and safety of treprostinil palmitil inhalation powder" in patients with pulmonary arterial hypertension, or PAH, and that the trial "met its primary endpoint and all secondary efficacy endpoints." Pulmonary hypertension, which develops when the blood pressure in your lungs is higher than normal, affects about 1% of people globally, per the National Heart, Lung, and Blood Institute. Insmed said it would "immediately engage with the U.S. Food and Drug Administration (FDA) regarding the Phase 3 trial design for PAH. Insmed plans to in...

Top stories of 2018 in greater Grand Rapids - MLive.com

1. PFAS: Continued investigation in Kent County

Garret Ellison | MLive.com

1. PFAS: Continued investigation in Kent County

PFAS: Hundreds sue Wolverine for damages

Neil Blake | MLive.com

PFAS: Hundreds sue Wolverine for damages

PFAS: Stalled negotiations on long-term water solution

Neil Blake | MLive.com

PFAS: Stalled negotiations on long-term water solution

PFAS: Blood draws begin in Kent County

PFAS: Blood draws begin in Kent County

2. Police-community relations: Ongoing discussion



http://bit.ly/2EWTnvw

Comments

Popular Posts

Model Monday's: Diana Moldovan

“Teaching a pandemic in real time, part 2 . Princeton professors share how they incorporate the study - Princeton University” plus 1 more

Preventing, controlling spread of animal diseases focus of forum at Penn State - Pennsylvania State University